• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C反应蛋白与血清白蛋白比值:COVID-19住院患者的一种可行的预后标志物

C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19.

作者信息

Giner-Galvañ Vicente, Pomares-Gómez Francisco José, Quesada José Antonio, Rubio-Rivas Manuel, Tejada-Montes Javier, Baltasar-Corral Jesús, Taboada-Martínez María Luisa, Sánchez-Mesa Blanca, Arnalich-Fernández Francisco, Del Corral-Beamonte Esther, López-Sampalo Almudena, Pesqueira-Fontán Paula María, Fernández-Garcés Mar, Gómez-Huelgas Ricardo, Ramos-Rincón José Manuel

机构信息

Department of Internal Medicine, Hospital Clínico Universitario San Juan de Alicante, 03550 Alicante, Spain.

Fundación para el Fomento de la Investigación Sanitaria y Biomédica (FISABIO), 46020 Valencia, Spain.

出版信息

Biomedicines. 2022 Jun 13;10(6):1393. doi: 10.3390/biomedicines10061393.

DOI:10.3390/biomedicines10061393
PMID:35740416
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC9219981/
Abstract

(1) Background: C-reactive protein (CRP) and albumin are inflammatory markers. We analyzed the prognostic capacity of serum albumin (SA) and CRP for an outcome comprising mortality, length of stay, ICU admission, and non-invasive mechanical ventilation in hospitalized COVID-19 patients. (2) Methods: We conducted a retrospective cohort study based on the Spanish national SEMI-COVID-19 Registry. Two multivariate logistic models were adjusted for SA, CRP, and their combination. Training and testing samples were used to validate the models. (3) Results: The outcome was present in 41.1% of the 3471 participants, who had lower SA (mean [SD], 3.5 [0.6] g/dL vs. 3.8 [0.5] g/dL; p < 0.001) and higher CRP (108.9 [96.5] mg/L vs. 70.6 [70.3] mg/L; p < 0.001). In the adjusted multivariate model, both were associated with poorer evolution: SA, OR 0.674 (95% CI, 0.551−0.826; p < 0.001); CRP, OR 1.002 (95% CI, 1.001−1.004; p = 0.003). The CRP/SA model had a similar predictive capacity (honest AUC, 0.8135 [0.7865−0.8405]), with a continuously increasing risk and cutoff value of 25 showing the highest predictive capacity (OR, 1.470; 95% CI, 1.188−1.819; p < 0.001). (4) Conclusions: SA and CRP are good independent predictors of patients hospitalized with COVID-19. For the CRP/SA ratio value, 25 is the cutoff for poor clinical course.

摘要

(1) 背景:C反应蛋白(CRP)和白蛋白是炎症标志物。我们分析了血清白蛋白(SA)和CRP对住院COVID-19患者包括死亡率、住院时长、入住重症监护病房(ICU)以及无创机械通气在内的预后情况的预测能力。(2) 方法:我们基于西班牙国家SEMI-COVID-19登记处进行了一项回顾性队列研究。针对SA、CRP及其组合调整了两个多变量逻辑模型。使用训练样本和测试样本对模型进行验证。(3) 结果:在3471名参与者中,41.1%出现了该预后情况,这些患者的SA较低(均值[标准差],3.5[0.6]g/dL vs. 3.8[0.5]g/dL;p<0.001)且CRP较高(108.9[96.5]mg/L vs. 70.6[70.3]mg/L;p<0.001)。在调整后的多变量模型中两者均与较差的病情进展相关:SA,比值比(OR)0.674(95%置信区间[CI],0.551 - 0.826;p<0.001);CRP,OR 1.002(95%CI,1.001 - 1.004;p = 0.003)。CRP/SA模型具有相似的预测能力(真实曲线下面积[AUC],0.8135[0.7865 - 0.8405]),风险持续增加,截断值为25时显示出最高的预测能力(OR,1.470;95%CI,1.188 - 1.819;p<0.001)。(4) 结论:SA和CRP是住院COVID-19患者良好的独立预测指标。对于CRP/SA比值,25是临床病程不佳的截断值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59ed/9219981/7c93d475e163/biomedicines-10-01393-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59ed/9219981/f42fcb7e4346/biomedicines-10-01393-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59ed/9219981/7c93d475e163/biomedicines-10-01393-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59ed/9219981/f42fcb7e4346/biomedicines-10-01393-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59ed/9219981/7c93d475e163/biomedicines-10-01393-g002.jpg

相似文献

1
C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19.C反应蛋白与血清白蛋白比值:COVID-19住院患者的一种可行的预后标志物
Biomedicines. 2022 Jun 13;10(6):1393. doi: 10.3390/biomedicines10061393.
2
The Impact of Serum Albumin Levels on COVID-19 Mortality.血清白蛋白水平对新冠病毒疾病死亡率的影响。
Infect Dis Rep. 2022 Apr 20;14(3):278-286. doi: 10.3390/idr14030034.
3
Does C reactive protein/Albumin ratio have prognostic value in patients with COVID-19.C 反应蛋白/白蛋白比值对 COVID-19 患者是否具有预后价值。
J Infect Dev Ctries. 2021 Aug 31;15(8):1086-1093. doi: 10.3855/jidc.14826.
4
Nutritional biomarkers as predictors of clinical outcomes between COVID-19 severity groups in a tertiary government hospital.营养生物标志物可预测三级政府医院 COVID-19 严重程度组之间的临床结局。
Clin Nutr ESPEN. 2023 Feb;53:134-143. doi: 10.1016/j.clnesp.2022.12.005. Epub 2022 Dec 6.
5
An inflammation-based prognostic score, the C-reactive protein/albumin ratio predicts the morbidity and mortality of patients on parenteral nutrition.基于炎症的预后评分,C 反应蛋白/白蛋白比值可预测肠外营养患者的发病率和死亡率。
Clin Nutr. 2018 Oct;37(5):1575-1583. doi: 10.1016/j.clnu.2017.08.013. Epub 2017 Aug 21.
6
C-reactive protein/albumin ratio predicts 90-day mortality of septic patients.C 反应蛋白/白蛋白比值预测脓毒症患者 90 天死亡率。
PLoS One. 2013;8(3):e59321. doi: 10.1371/journal.pone.0059321. Epub 2013 Mar 12.
7
Prognostic value of serum albumin combined with serum C-reactive protein levels in older hospitalized patients: continuing importance of serum albumin.血清白蛋白联合血清C反应蛋白水平对老年住院患者的预后价值:血清白蛋白的持续重要性
Aging Clin Exp Res. 2006 Aug;18(4):307-11. doi: 10.1007/BF03324664.
8
The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy.术前高敏 C 反应蛋白/白蛋白比值对经皮肾镜取石术后全身炎症反应综合征的预测价值。
J Endourol. 2019 Jan;33(1):1-8. doi: 10.1089/end.2018.0632. Epub 2018 Dec 26.
9
[Retrospective analysis of serum C-reactive protein/albumin ratio for the prognosis of the adult patients with sepsis].血清C反应蛋白/白蛋白比值对成年脓毒症患者预后的回顾性分析
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 May;28(5):413-7.
10
Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.利用 C 反应蛋白与白蛋白比值对重症 COVID-19 患者的疾病进展进行早期预测。
Dis Markers. 2021 Dec 3;2021:6304189. doi: 10.1155/2021/6304189. eCollection 2021.

引用本文的文献

1
Biomarker Patterns and Their Association with Lung Injury in COVID-19 Patients.新型冠状病毒肺炎患者的生物标志物模式及其与肺损伤的关联
Medicina (Kaunas). 2025 May 21;61(5):931. doi: 10.3390/medicina61050931.
2
Association between the C-reactive protein to albumin ratio with asthma and mortality in adult: a population-based study.C 反应蛋白与白蛋白比值与成人哮喘及死亡率的相关性:一项基于人群的研究。
Sci Rep. 2024 Sep 4;14(1):20573. doi: 10.1038/s41598-024-71754-z.
3
Prognostic Value of D-dimer to Lymphocyte Ratio (DLR) in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients: A Validation Study in a National Cohort.

本文引用的文献

1
Nutritional and Functional Impact of Acute SARS-CoV-2 Infection in Hospitalized Patients.新型冠状病毒2型急性感染对住院患者的营养和功能影响
J Clin Med. 2022 Apr 26;11(9):2424. doi: 10.3390/jcm11092424.
2
A combined role for low vitamin D and low albumin circulating levels as strong predictors of worse outcome in COVID-19 patients.维生素 D 水平低和循环白蛋白水平低的综合作用是 COVID-19 患者预后不良的强有力预测因子。
Ir J Med Sci. 2023 Feb;192(1):423-430. doi: 10.1007/s11845-022-02952-9. Epub 2022 Feb 19.
3
Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis.
D-二聚体与淋巴细胞比值(DLR)对住院的 2019 年冠状病毒病(COVID-19)患者的预后价值:一项全国队列的验证研究。
Viruses. 2024 Feb 22;16(3):335. doi: 10.3390/v16030335.
4
Circulating mid-regional proadrenomedullin is a predictor of mortality in patients with COVID-19: a systematic review and meta-analysis.循环中脑钠肽前体是 COVID-19 患者死亡率的预测指标:系统评价和荟萃分析。
BMC Infect Dis. 2023 May 8;23(1):305. doi: 10.1186/s12879-023-08275-z.
5
Infections and immunity: associations with obesity and related metabolic disorders.感染与免疫:与肥胖及相关代谢紊乱的关联
J Pathol Transl Med. 2023 Jan;57(1):28-42. doi: 10.4132/jptm.2022.11.14. Epub 2023 Jan 15.
严重和致命 COVID-19 感染患者免疫功能障碍的代表性参数的识别:系统评价和荟萃分析。
Clin Rev Allergy Immunol. 2023 Feb;64(1):33-65. doi: 10.1007/s12016-021-08908-8. Epub 2022 Jan 18.
4
Clinical and prognostic significance of C-reactive protein to albumin ratio in hospitalized coronavirus disease 2019 (COVID-19) patients : Data on 2309 patients from a tertiary center and validation in an independent cohort.住院的 2019 冠状病毒病(COVID-19)患者 C 反应蛋白与白蛋白比值的临床和预后意义:来自一家三级中心的 2309 例患者数据及在独立队列中的验证。
Wien Klin Wochenschr. 2022 May;134(9-10):377-384. doi: 10.1007/s00508-021-01999-5. Epub 2022 Jan 17.
5
Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.利用 C 反应蛋白与白蛋白比值对重症 COVID-19 患者的疾病进展进行早期预测。
Dis Markers. 2021 Dec 3;2021:6304189. doi: 10.1155/2021/6304189. eCollection 2021.
6
Relationships of the neutrophil-lymphocyte and CRP-albumin ratios with the duration of hospitalization and fatality in geriatric patients with COVID-19.中性粒细胞与淋巴细胞比值和 C 反应蛋白与白蛋白比值与 COVID-19 老年患者住院时间和病死率的关系。
J Int Med Res. 2021 Sep;49(9):3000605211046112. doi: 10.1177/03000605211046112.
7
The value of C-reactive protein/albumin, fibrinogen/albumin, and neutrophil/lymphocyte ratios in predicting the severity of CoVID-19.C 反应蛋白/白蛋白、纤维蛋白原/白蛋白和中性粒细胞/淋巴细胞比值在预测 CoVID-19 严重程度中的价值。
Rev Assoc Med Bras (1992). 2021 Mar;67(3):431-436. doi: 10.1590/1806-9282.20200883.
8
The sufficient vitamin D and albumin level have a protective effect on COVID-19 infection.足够的维生素 D 和白蛋白水平对 COVID-19 感染有保护作用。
Arch Microbiol. 2021 Oct;203(8):5153-5162. doi: 10.1007/s00203-021-02482-5. Epub 2021 Jul 30.
9
[Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry].[西班牙新冠肺炎住院患者的临床特征:SEMI-COVID-19登记研究结果]
Rev Clin Esp. 2020 Nov;220(8):480-494. doi: 10.1016/j.rce.2020.07.003. Epub 2020 Jul 19.
10
Low serum albumin and the risk of hospitalization in COVID-19 infection: A retrospective case-control study.血清白蛋白水平低与 COVID-19 感染住院风险的关系:一项回顾性病例对照研究。
PLoS One. 2021 Apr 30;16(4):e0250906. doi: 10.1371/journal.pone.0250906. eCollection 2021.